Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, NF-κB and AP-1 related mechanisms

Lignende værker

• Dynamic Effect of Bortezomib on NF-κB Activity and Gene Expression in Tumor Cells
  af: Sung, Myong-Hee, et al.
  Udgivet: (2008)
• CCR 20th Anniversary Commentary: Preclinical Study of Proteasome Inhibitor Bortezomib in Head and Neck Cancer
  af: Allen, Clint T., et al.
  Udgivet: (2015)
• Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer
  af: Nottingham, Liesl K., et al.
  Udgivet: (2013)
• Chemoprevention of Head and Neck Squamous Cell Carcinoma through Inhibition of NF-κB Signaling
  af: Vander Broek, Robert, et al.
  Udgivet: (2013)
• Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?
  af: Morgan, Ethan L., et al.
  Udgivet: (2020)